Caption Management, LLC Novo Cure LTD Put Options Transaction History

Caption Management, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$12.42 - $17.29 $2.44 Million - $3.39 Million	196,200 New	196,200 $3.07 Million
Q1 2023 May 15, 2023	BUY	$56.44 - $118.81 $5.85 Million - $12.3 Million	103,700 Added 60.54%	275,000 $16.5 Million
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $2.3 Million - $3.07 Million	36,000 Added 26.61%	171,300 $12.6 Million
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $3.16 Million - $4.17 Million	46,500 Added 52.36%	135,300 $10.3 Million
Q2 2022 Aug 15, 2022	BUY	$56.6 - $89.9 $2.2 Million - $3.49 Million	38,800 Added 77.6%	88,800 $6.17 Million

Q1 2022 May 13, 2022	SELL	$60.15 - $84.52 $5.29 Million - $7.44 Million	-88,000 Reduced 63.77%	50,000 $4.14 Million
Q3 2021 Nov 12, 2021	BUY	$116.17 - $194.55 $10.2 Million - $17.1 Million	88,000 Added 176.0%	138,000 $16 Million
Q2 2021 Aug 16, 2021	SELL	$130.4 - $225.58 $9.01 Million - $15.6 Million	-69,100 Reduced 58.02%	50,000 $11.1 Million
Q4 2020 Feb 16, 2021	BUY	$112.16 - $174.14 $13.4 Million - $20.7 Million	119,100 New	119,100 $20.6 Million

277

73.2M

1.43M

832K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.76B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.